Huntington National Bank Increases Stock Position in Amdocs Limited (NASDAQ:DOX)

Share on StockTwits

Huntington National Bank boosted its stake in Amdocs Limited (NASDAQ:DOX) by 7.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,856 shares of the technology company’s stock after acquiring an additional 202 shares during the period. Huntington National Bank’s holdings in Amdocs were worth $189,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Mitsubishi UFJ Securities Holdings Co. Ltd. purchased a new stake in shares of Amdocs in the second quarter valued at about $47,000. Morgan Dempsey Capital Management LLC raised its holdings in shares of Amdocs by 110.0% in the second quarter. Morgan Dempsey Capital Management LLC now owns 905 shares of the technology company’s stock valued at $56,000 after buying an additional 474 shares during the last quarter. Steward Partners Investment Advisory LLC purchased a new stake in shares of Amdocs in the second quarter valued at about $60,000. CENTRAL TRUST Co raised its holdings in shares of Amdocs by 56.2% in the second quarter. CENTRAL TRUST Co now owns 1,098 shares of the technology company’s stock valued at $69,000 after buying an additional 395 shares during the last quarter. Finally, Cullen Frost Bankers Inc. purchased a new stake in shares of Amdocs in the second quarter valued at about $73,000. 92.32% of the stock is owned by hedge funds and other institutional investors.

DOX has been the subject of a number of research reports. JPMorgan Chase & Co. upped their target price on shares of Amdocs from $67.00 to $75.00 and gave the company a “neutral” rating in a report on Thursday, August 8th. Zacks Investment Research cut shares of Amdocs from a “buy” rating to a “hold” rating and set a $67.00 target price for the company. in a report on Tuesday, July 16th. Finally, BidaskClub cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 15th. Three investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $71.00.

NASDAQ DOX traded up $0.62 during trading hours on Friday, hitting $67.12. 695,600 shares of the stock were exchanged, compared to its average volume of 839,539. The stock has a 50-day moving average of $65.80 and a 200 day moving average of $62.67. The company has a market cap of $9.20 billion, a price-to-earnings ratio of 17.95, a price-to-earnings-growth ratio of 1.81 and a beta of 0.39. Amdocs Limited has a 12-month low of $52.60 and a 12-month high of $67.57.

Amdocs (NASDAQ:DOX) last released its quarterly earnings results on Wednesday, August 7th. The technology company reported $1.19 EPS for the quarter, beating the consensus estimate of $1.11 by $0.08. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Amdocs had a net margin of 9.90% and a return on equity of 15.70%. The company’s quarterly revenue was up 2.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.03 earnings per share. On average, analysts expect that Amdocs Limited will post 4.05 earnings per share for the current year.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.

Featured Article: Margin

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.